As we all know, there are interesting examples of corporate ecosystems built around open standards leading to thriving markets and improved quality of life. Want a good example? Here's one. The Internet would never have been invented by the incumbent phone companies. In fact, they thought of it as a toy, and resisted it until they realized it was inevitable, and then they embraced it. Now, it is an integral part of their thriving business.
Like the telephone companies, the diabetes device vendors are not going to invent an open data platform for diabetes because they are happy with the status quo. In fact, they will probably oppose it until it becomes a wave they cannot resist, and only then will they embrace it. This rising tide will make life better for the entire device industry.
Where does the FDA fit into the picture? We see a world where a range of FDA-approved cloud-based data providers interoperate with FDA-approved devices from a range of vendors, with third-party FDA-approved apps that ride on top of this platform, and it's all safe and effective. This is new territory for the FDA but it's how the world works everywhere from cloud storage to mobile operating systems to banking.
Done right, applying open standards to diabetes management will improve the lives of millions of people, as well as the people who help provide their care. Done right, it will revolutionize the clinical practices of diabetes management.